Company profile

Ticker
BDX
Exchange
Website
CEO
Vincent A. Forlenza
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
220760120

BDX stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

6 Feb 20
5 Apr 20
30 Sep 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 4.23B 4.58B 4.35B 4.2B
Net income 278M 163M 451M 20M
Diluted EPS 0.87 0.45 1.51 -0.07
Net profit margin 6.58% 3.56% 10.37% 0.48%
Operating income 501M 111M 626M 136M
Net change in cash 24M 13M -163M -257M
Cash on hand 560M 536M 523M 686M
Cost of revenue 2.25B 2.32B 2.28B 2.22B
Annual (USD) Sep 19 Sep 18 Sep 17 Sep 16
Revenue 17.29B 15.98B 12.09B 12.48B
Net income 1.23B 311M 1.1B 976M
Diluted EPS 3.94 0.6 4.6 4.49
Net profit margin 7.13% 1.95% 9.10% 7.82%
Operating income 1.76B 1.51B 1.52B 1.43B
Net change in cash -604M -13.04B 12.64B 117M
Cash on hand 536M 1.14B 14.18B 1.54B
Cost of revenue 9B 8.71B 6.13B 6.49B

Financial data from company earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
16 Mar 20 Khichi Samrat S. Common Stock Sell Dispose S 224.53 4,349 976.48K 5,262
19 Feb 20 Khichi Samrat S. Common Stock Gift Dispose G 0 195 0 9,611
14 Feb 20 Bertram L Scott Rights to Common Stock Under 1996 Directors Deferral Plan Common Stock Grant Aquire A 275.18 188 51.73K 15,456
14 Feb 20 Christopher Ian Montague Jones Rights to Common Stock Under 1996 Directors Deferral Plan Common Stock Grant Aquire A 275.18 188 51.73K 7,165
11 Feb 20 Claire Fraser Common Stock Sell Dispose S 258.7 700 181.09K 20,939
11 Feb 20 Claire Fraser Common Stock Sell Dispose S 258.73 800 206.98K 21,639
83.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1428 1374 +3.9%
Opened positions 146 102 +43.1%
Closed positions 92 76 +21.1%
Increased positions 503 500 +0.6%
Reduced positions 505 504 +0.2%
13F shares
Current Prev Q Change
Total value 61.94B 56.82B +9.0%
Total shares 227.62M 224.57M +1.4%
Total puts 1M 937.77K +6.8%
Total calls 758.88K 502.05K +51.2%
Total put/call ratio 1.3 1.9 -29.3%
Largest owners
Shares Value Change
N Price T Rowe Associates 27.72M $7.54B -13.2%
Vanguard 23.54M $6.4B +1.1%
BLK BlackRock 19.02M $5.17B -7.2%
FMR 13.47M $3.66B +4.1%
STT State Street 11.45M $3.11B +1.7%
MS Morgan Stanley 5.85M $1.59B +16.4%
Geode Capital Management 3.69M $1B +3.5%
WFC Wells Fargo & Co. 3.65M $992.19M +6.0%
BEN Franklin Resources 3.61M $983.02M -0.3%
JPM JPMorgan Chase & Co. 3.47M $943.05M -21.3%
Largest transactions
Shares Bought/sold Change
N Price T Rowe Associates 27.72M -4.2M -13.2%
Norges Bank 2.29M +2.29M NEW
Wellington Management 2.6M +2.07M +385.9%
BLK BlackRock 19.02M -1.47M -7.2%
Massachusetts Financial Services 3.2M +1.05M +48.7%
JPM JPMorgan Chase & Co. 3.47M -940.56K -21.3%
MS Morgan Stanley 5.85M +824.26K +16.4%
American Century Companies 616.85K -579.36K -48.4%
PRU Prudential Financial 815.12K +568.37K +230.3%
M&G Investment Management 541.72K +541.72K NEW

Financial report summary

?
Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • Becton, Dickinson and Company (“BD”) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's organizational structure is based upon three principal business segments, BD Medical (“Medical”), BD Life Sciences (“Life Sciences”) and BD Interventional (“Interventional”).
  • BD’s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: Europe; EMA (which includes the Commonwealth of Independent States, the Middle East and Africa); Greater Asia (which includes countries in East Asia, South Asia, Southeast Asia and the Oceania region); Latin America (which includes Mexico, Central America, the Caribbean, and South America); and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and certain countries within Greater Asia. We are primarily focused on certain countries whose healthcare systems are expanding.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Addendum, AlarisTM, alarm, arrangement, automated, automation, begun, bidding, blood, cancer, capacity, cervical, complaint, counsel, Covington, culturing, cytology, demonstrate, Director, disciplined, Division, enjoin, EPD, estate, ethylene, exercise, Exhibit, explicitly, French, Georgia, hosting, identification, implicit, implicitly, incremental, Interactive, introduction, joined, labor, Madison, medicine, microorganism, motion, necessity, Oceania, ongoing, option, oxide, Page, plated, prioritization, procurement, protectionist, rapid, readily, real, rental, respiratory, restated, restraining, screening, situation, Southeast, specimen, Spoerel, spread, sterilization, strain, susceptibility, temporary, terrorism, testing, trend, valuation, Violation, voluntarily, voluntary, war, XBRL
Removed: acceptance, acquired, adjust, advance, Affordable, allocated, allocation, anticipation, ASC, assertion, assessed, assessment, assumed, Codification, commercially, commonly, complex, confirmed, depending, determining, dilutive, disaggregated, discontinued, ending, entitled, entity, excise, exclude, excluded, exclusion, expedient, finalization, finalized, fulfillment, good, hand, handling, identifiable, imported, inclusion, incorporate, individual, installation, instrument, Japan, lag, loan, manner, MAXTM, modified, monitoring, offered, omitted, oversight, Pacific, permanent, platform, postretirement, primary, profile, promised, quantification, ratably, reagent, rebate, reevaluation, reflective, reinvestment, remeasured, renewal, retrospective, retrospectively, scope, shipment, shipping, specifically, standalone, subtotal, suspended, suspension, Topic, transit, typical, typically, Virginia, West, York